Two ceftazidime-resistant variants of Pseudomonas aeruginosa (PA-48, PA-60), obtained from cardiac vegetations of rabbits with endocarditis receiving ceftazidime therapy, were studied for mechanisms of resistance. Both resistant variants were stably derepressed for the type Id I-lactamase, which was ceftazidime inducible in the parental strain (PA-96) used to initially infect the rabbits. There was no evidence of ceftazidime bioinactivation by the resistant strains, and their outer membrane permeabilities were comparable to those of the parental strain. No alterations were observed in patterns of outer membrane proteins or membrane lipopolysaccharides in the resistant variants as compared with the parental strain. Penicillin-binding protein patterns of the resistant variants revealed the absence of penicillin-binding protein 4 in both, with acquisition of a new protein of higher apparent molecular weight in PA-60. Calculation of the rate of appearance of ceftazidime in the periplasm at sub-MICs suggested that slow enzymatic hydrolysis of the P-lactam, rather than nonhydrolytic trapping, was the major explanation for the induced resistance in vivo in strains PA-48 and PA-60.
also been observed (26) but seem to occur with somewhat less frequency. One novel approach taken by pharmaceutical companies in the development of newer ,-lactam antibiotics has been to search for compounds that are refractory to ,-lactamase-mediated hydrolysis. Recently, however, it has been observed that, despite the extremely low rates at which these compounds are hydrolyzed, clinical isolates of P. aeruginosa and Enterobacter cloacae that are resistant to these so-called P-lactamase-stable P-lactams often have much-increased levels of the chromosomal P-lactamase (4, 30, 31, (34) (35) (36) . The mechanism of resistance has been suggested to involve nonhydrolytic binding of the ,-lactam by molecules of ,-lactamase, thus reducing the periplasmic concentration (i.e., the concentration in the vicinity of the target PBPs) to subinhibitory levels (34) . Alternatively, Vu and Nikaido (35) have argued convincingly that a combination of low-level hydrolysis by ,-lactamase (low Km. low Vmax) and reduced outer membrane permeability, thus di-minishing the rate of buildup of periplasmic 1-lactam concentrations, is the actual mechanism of resistance.
Analysis of resistant clinical isolates presents a major problem, since it is difficult to obtain with certainty the control (parental) susceptible strain from which the resistant isolate arose. This makes characterization of antibiotic resistance, which may be multifactorial, problematic. In the current investigation, we have utilized an animal model infection to overcome these problems. The resistant isolates we studied arose during ceftazidime therapy of experimental P. aeruginosa endocarditis in rabbits (2) . Our results confirm that strains with derepressed chromosomal P-lactamase production can arise during therapy and suggest that the overproduction of P-lactamase is the most significant cause of resistance.
MATERIALS AND METHODS
Bacterial strains. PA-96 was a clinical isolate of P. aeruginosa that was used to initially infect catheterized rabbits to induce experimental aortic valve endocarditis (2) . Its identification, serotyping, and rabbit serum resistance have been previously described (2) . Most ,-lactams tested have moderate MICs for this strain (2), including ceftazidime (8 ,ug/ml), cefoperazone (16 ,ug/ml), and moxalactam (32 ,ug/ml). A detailed description of the induction, antimicrobial therapy, and timing of development of P-lactam resistances has been recently reported (2) . Two ceftazidime-resistant variants (PA-48 and PA-60), utilized in the current investigations, were isolated directly from homogenates of cardiac vegetations subcultured onto agar containing ceftazidime (50 p.g/ml). Both ceftazidime-resistant variants (MIC, >128 ,ug/ml) were cross resistant to cefoperazone (>64 ,ug/ml) and moxalactam (>64 ,ug/ml). In addition, these variants were stable in vitro, since after 15 serial passages in antibiotic-free ANTIMICROB. AGENTS CHFMOTHER. Characterization of P-lactamases by gel electrophoresis and isoelectric focusing. The periplasmic ,-lactamase extracts from the parental and ceftazidime-resistant variants, prepared as described -above, were electrophoresed under dissociating conditions by the method Laemmli (17) with 10% polyacrylamide slab gels (sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE]). Samples (75 ,ug) of protein were loaded per lane from each extract, and the resolved polypeptides were stained with Coomassie blue.
Isoelectric focusing was performed in duplicate under both native and denaturing conditions in a model 175 tube cell (Bio-Rad Laboratories) as described Benya (3), except that under native conditions urea was omitted from the loading buffer and gel. After focusing, the pH gradient was confirmed by sectioning the gels into 10 1-cm slices and eluting each slice separately into 2.0 ml of degassed KCl (0.10 M) in sealed vials. Native gels were activity stained for 1-lacctamase by overlaying'tube gels with MH agar containing 50 ,ug of nitrocefin per ml. The appearance of pink bands within the gels localized P-lactamase activity (8) .
Two-dimensional separations were performed with isoelectric focusing as the first dimension and SDS-PAGE as the second dimensiQn as described by O'Farrell (25) . Slab gels were stained for protein with silver stain.
Outer membrane permeability assays. Outer membrane permeability was assessed by a modification of the technique of Zimmerman and Rosselet (40) with nitrocefin as previously described (27) . To allow direct comparisons of uninduced strains, the TEM-2 P-lactamase from plasmid R68.45 was introduced into strains PA-96 and PA-60 by conjugating these strains with P. aeruginosa H762 (an arginine auxotroph of P. aeruginosa PAO carrying plasmid R68.45), as previously described (21) . Transconjugants of PA-96 and PA-60 carrying R68.45 were isolated on BM2 minimal succinate medium (9) by using the lack of arginine in the plates as a counterselection against the donor and 300 ,ug of kanamycin per ml or 500 ,g of carbenicillip per ml as the selective agent. For outer membrane permeability studies, cultures were grown to an optical density at 600 nm of 0.5 to 0.8.
Cell envelope and PBP analyses. For lipopolysaccharide analyses, the method of Hitchcock and Brown (12) was used. Outer and inner membranes were isolated by utilizing differential sucrose gradients by the method of Hancock and Nikaido (9) . PBP analyses of inner membrane proteins were performed after two cycles of suspension of inner membranes in 10 mM Tris hydrochloride (pH 8.0) and sonication followed by centrifugation at 150,000 x g for 1 h. This treatment was required to extract ,B-lactamase from inner m,embrane preparations (T. R. Parr, L. Chan, A. S. Bayer, and R. E. W. Hancock, submitted for publication). PBPs were analyzed as described by' Spratt (33) with 35S-labeled benzyl penicillin (New England Nuclear Corp., Boston, Mass.; 3.7 Ci/mmol; 12.5 p.g of benzylpenicillin per ml, final concentration). SDS-PAGE was carried out as described previously (1) . RESULTS 3-Lactamase activity. Preliminary studies on Frenchpressed broken cells of PA-48 and PA-60 indicated that these variants had far greater basal levels of P-lactamase than the parental strain (PA-96). This was confirmed by analysis of the P-lactamase'activities of the periplasmic extracts of these strains (Table 1) . Both PA-48 and PA-60 had significantly higher levels of 1-lactamase activities for both cephalothin (Table 1 ) and cephaloridine (data not shown) in the basal (urninduced) states than the parent strain (>90 to 300 times, respectively, for' cephalothin). Induction of PA-96 by a sub-MIC of ceftazidime resulted in an approximately eightfold increase in P-lactamase activity over the uninduced 254 BAYER ET AL. (35), we attempted to demonstrate hydrolysis of ceftazidime at low substrate concentrations by periplasmic P-lactamase extracts of PA-48 or PA-96 (postinduction). Each of these extracts hydrolyzed nitrocefin, (as assayed by an increase in A520) and cephaloridine (as assayed by a decrease in A260).
The Km values obtained from these latter assays for nitrocefin and cephaloridine hydrolysis by strain PA-48 were consistent with previously reported values for the inducible type ID P-lactam of P. aeruginosa (Table 2 ). In contrast, inconsistent hydrolysis of ceftazidime.was mneasured at low substrate concentrations (0.5 to 10 ,LM; Fig. 1 ). The slow decreases in A257 seen in some assays were apparently unrelated to the substrate concentration used. Since the change in absorbance at low substrate concentrations upon complete hydrolysis with base was minimal (e.g., 3 ,uM ceftazidime yielded 0.02 absorbance unit), this precluded a study at lower concentrations. Thus, we were unable to directly demonstrate ceftazidime hydrolysis by the periplasmic P-lactamase of the resistant variant (PA-48) or induced parental strain (PA-96).
In contradistinction, ceftazidime acted as an efficient competitive inhibitor of nitrocefin hydrolysis by periplasmic 1-lactamase of variant strain PA-48 (Fig. 2) . 11.4 ± 1.3 pFM was obtained, in agreement with literature values for inducible, type Id chromosomal 1-lactamases shared by all P. aeruginosa strains ( Table 2 ). The properties of the induced ,-lactamase from the parent strain (PA-96) and the constitutive ,B-lactamase from the resistant variant PA-60 were not as exhaustively studied; however, the similar Km values for nitrocefin and cephaloridine and identical molecular weights for these enzymes (data not shown) suggested that they too were typical type Id chromosomal ,-lactamases of P. aeruginosa (6) .
,-Lactainase characterizations. The salient difference between the complement of periplasmic proteins in the two ceftazidime-resistant variants and the parental strain was the presence of a major band at -41,000 molecular weight in the variants but not in the uninduced parent (data not shown). Of note, this band became prominent in the parental strain after exposure to a sub-MIC of ceftazidime (4 ,ug/ml) (data not shown). It was confirmed by isoelectric focusing and twodimnensional electrophoresis that the P-lactamase activity with a pl of 8.0 had an apparent molecular weight of -40,000, in close agreement with molecular weight data from one-dimensional SDS-PAGE. Moreover, the results of the molecular weight and pl studies are in close agreement with those previously published for typical type Id chromosomal P-lactamases of P. aeruginosa (3, 20) (Table 2) . (2, 8, (28) (29) (30) . However, the exact mechanisms of resistance have not been delineated in most of the clinically derived strains from these reports. The current study investigated possible mechanisms involved in the in vivo development of ceftazidime resistance in two pseudomonal variants, in direct comparison to the ceftazidime-susceptible, parental strain. The ceftazidime-resistant variants were stably derepressed for a Plactamase that was normally inducible in the parental strain. The stable derepression, molecular weights and pl profile of this ,-lactamase, in addition to its Kms for cephaloridine and nitrocefin and the Ki for ceftazidime, are characteristic of the type Id P-lactamase of P. aeruginosa (6, 20) . Structurefunction studies of the outer membrane of the two variants eliminated alterations in the lipopolysaccharide profile (7) , changes in the porin or other major outer membrane proteins, or decreases in outer membrane permeability as the cause of ceftazidime resistance. Additionally, there was no evidence for bioinactivation of ceftazidime by the resistant variants, and only the absence of PBP 4, an enzyme with no major discernible function in P. aeruginosa, was different when the PBP profiles of the resistant variants were compared with that of the parental strain.
P. aeruginosa has been shown to possess six PBPs designated 1A, 1B, 2, 3, 4, and 5 (24) . Only one of these, PBP (33) . For these reasons, it is difficult to envision PBP 4 as a primary target for ceftazidime in P. aeruginosa, and consequently its mutational loss should not result in ceftazidime resistance. Moreover, the studies of Hayes and Orr demonstrated that ceftazidime has substantially higher affinity for PBPs 3 and 1A of susceptible P. aeruginosa strains than for PBP 4 (11) . PBPs 3 and 1A were apparently unaltered in the ceftazidimeresistant variants we examined.
It appears most likely that the ceftazidime resistance in variants PA-48 and PA-60 was related to the derepression of chromosomal type Id P-lactamase. Such strains have been sporadically isolated from clinical specimens and from laboratory-derived mutants, although to our knowledge this is the first report where such strains were isolated from a clinically relevant, controlled animal model (8, 14, 18, 28, 30, 37) . Two mechanisms have been described whereby derepressioh of ,-lactamase gives rise to resistance to 1-lactamase stable or nonhydrolyzable ,B-lactams (16, 19) We therefore postulate that slow ceftazidime hydrolysis, rather than nonhydrolytic 3-lactamase trapping, must be the principal mechanism of resistance in these P. aeruginosa strains.
